Oncofetal Chondroitin Sulfate: A Putative Therapeutic Target in Adult and Pediatric Solid Tumors

被引:12
作者
Khazamipour, Nastaran [1 ,2 ]
Al-Nakouzi, Nader [1 ,2 ]
Oo, Htoo Zarni [1 ,2 ]
Orum-Madsen, Maj [1 ,2 ]
Steino, Anne [2 ,3 ]
Sorensen, Poul H. [3 ,4 ]
Daugaard, Mads [1 ,2 ]
机构
[1] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada
[2] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada
[3] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
[4] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada
关键词
oncofetal chondroitin sulfate; chondroitin sulfate; cancer; solid tumors; target; pediatric cancer; VAR2; LAMININ RECEPTOR PROTEIN; GROWTH-FACTOR RECEPTOR; ANTIGEN; 5T4; TROVAX; CANCER PATIENTS; HUMAN-PLACENTA; MYC ONCOGENE; GLYCOSAMINOGLYCAN BINDING; TROPHOBLAST PROLIFERATION; PLASMODIUM-FALCIPARUM; PERICELLULAR MATRIX;
D O I
10.3390/cells9040818
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Solid tumors remain a major challenge for targeted therapeutic intervention strategies such as antibody-drug conjugates and immunotherapy. At a minimum, clear and actionable solid tumor targets have to comply with the key biological requirement of being differentially over-expressed in solid tumors and metastasis, in contrast to healthy organs. Oncofetal chondroitin sulfate is a cancer-specific secondary glycosaminoglycan modification to proteoglycans expressed in a variety of solid tumors and metastasis. Normally, this modification is found to be exclusively expressed in the placenta, where it is thought to facilitate normal placental implantation during pregnancy. Informed by this biology, oncofetal chondroitin sulfate is currently under investigation as a broad and specific target in solid tumors. Here, we discuss oncofetal chondroitin sulfate as a potential therapeutic target in childhood solid tumors in the context of current knowhow obtained over the past five years in adult cancers.
引用
收藏
页数:12
相关论文
共 109 条
[71]   Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance [J].
Peng, Shaoyong ;
Huang, Pinzhu ;
Yu, Huichuan ;
Wen, Yanlin ;
Luo, Yanxin ;
Wang, Xiaolin ;
Zhou, Jiaming ;
Qin, Si ;
Li, Tuoyang ;
Chen, Yao ;
Liu, Guangjian ;
Huang, Meijin .
MEDICINE, 2018, 97 (10)
[72]   Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1 [J].
Pereira, Marina Ayres ;
Clausen, Thomas Mandel ;
Pehrson, Caroline ;
Mao, Yang ;
Resende, Mafalda ;
Daugaard, Mads ;
Kristensen, Anders Riis ;
Spliid, Charlotte ;
Mathiesen, Line ;
Knudsen, Lisbeth E. ;
Damm, Peter ;
Theander, Thor G. ;
Hansson, Stefan R. ;
Nielsen, Morten A. ;
Salanti, Ali .
PLOS PATHOGENS, 2016, 12 (08)
[73]   Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells [J].
Peters, Haley L. ;
Yan, Ying ;
Nordgren, Tara M. ;
Cutucache, Christine E. ;
Joshi, Shantaram S. ;
Solheim, Joyce C. .
CANCER BIOLOGY & THERAPY, 2013, 14 (08) :752-760
[74]   SPATIAL AND TEMPORAL PATTERN OF CELLULAR MYC ONCOGENE EXPRESSION IN DEVELOPING HUMAN-PLACENTA - IMPLICATIONS FOR EMBRYONIC-CELL PROLIFERATION [J].
PFEIFEROHLSSON, S ;
GOUSTIN, AS ;
RYDNERT, J ;
WAHLSTROM, T ;
BJERSING, L ;
STEHELIN, D ;
OHLSSON, R .
CELL, 1984, 38 (02) :585-596
[75]   Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth [J].
Pietras, Alexander ;
Katz, Amanda M. ;
Ekstroem, Elin J. ;
Wee, Boyoung ;
Halliday, John J. ;
Pitter, Kenneth L. ;
Werbeck, Jillian L. ;
Amankulor, Nduka M. ;
Huse, Jason T. ;
Holland, Eric C. .
CELL STEM CELL, 2014, 14 (03) :357-369
[76]   Extension and Validation of the GROMOS 53A6GLYC Parameter Set for Glycoproteins [J].
Pol-Fachin, Laercio ;
Verli, Hugo ;
Lins, Roberto D. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2014, 35 (29) :2087-2095
[77]  
Pomin V.H., 2018, PHARMACEUTICALS, V27, P11
[78]  
Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9
[79]   CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma [J].
Price, Matthew A. ;
Wanshura, Leah E. Colvin ;
Yang, Jianbo ;
Carlson, Jennifer ;
Xiang, Bo ;
Li, Guiyuan ;
Ferrone, Soldano ;
Dudek, Arkadiusz Z. ;
Turley, Eva A. ;
McCarthy, James B. .
PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (06) :1148-1157
[80]   The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer [J].
Pudelko, Adam ;
Wisowski, Grzegorz ;
Olczyk, Krystyna ;
Kozma, Ewa Maria .
FEBS JOURNAL, 2019, 286 (10) :1815-1837